logo

For the Inventor, By the Inventor

Nagoya, Japan

Juichi Awaya

This inventor holds 5 USPTO granted patents. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1989-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juichi Awaya. Retrieved from https://idiyas.com/inventor/juichi-awaya-pg8fz0j9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Nagoya, JP (1989 - 1994)
  • Aichi, JP (1995)

Company Filing History:

goldMedal5 out of 108 
 
Sanwa Kagaku Kenkyusho Co., Ltd.
 patents

Years Active: 1989-1995

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5464818 - Protein having cell growth-stimulating and macrophage chemotactic (1995-11-07),
2. 5340806 - Composition containing organogermanium compound and immunity adjusting (1994-08-23),
3. 5336688 - Composition containing organogermanium compound and immunity adjusting (1994-08-09),
4. 5290679 - Method of predicting threatened premature delivery in a pregnant woman (1994-03-01),
5. 4889715 - Composition containing organogermanium compound and immunity adjusting (1989-12-26),

Title: Juichi Awaya: Innovator in Protein Research

Introduction

Juichi Awaya is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of protein research, holding a total of 5 patents. His work focuses on developing novel proteins with therapeutic applications, particularly in wound healing and immune system modulation.

Latest Patents

One of Awaya's latest patents involves a protein derived from Clostridium perfringens FERM BP-4584. This protein has a molecular weight of 420,000 ± 40,000, with an isoelectric point of 4.8. It consists of a single subunit with a molecular weight of 130,000 ± 20,000, as determined by SDS-polyacrylamide gel electrophoresis. The protein exhibits cell growth-stimulating activity and macrophage chemotactic action, making it a promising candidate for treating wounds and ulcers. Another notable patent describes a composition containing an organogermanium compound, which serves as an immunity adjusting agent. This composition is particularly relevant for the treatment of hepatitis.

Career Highlights

Juichi Awaya is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to advance his research in protein applications. His innovative work has garnered attention in the scientific community, contributing to the understanding of protein functions in medical treatments.

Collaborations

Awaya has collaborated with notable colleagues such as Kiichi Sawai and Masayasu Kurono. Their combined expertise has furthered research initiatives and enhanced the development of new therapeutic solutions.

Conclusion

Juichi Awaya's contributions to protein research highlight his role as an influential inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…